Non-alcoholic fatty liver disease (NAFLD) is a prevalent liver condition characterized by excessive fat accumulation in the liver of individuals…
On April 18, 2023, Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that its drug candidate resmetirom has received the Breakthrough…